PSRF:LSE:LSE-Invesco Markets III plc - Invesco FTSE RAFI US 1000 UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 2507

Change

0.00 (0.00)%

Market Cap

USD 0.50B

Volume

2.91K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 652.47B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 650.46B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 330.91B

ETFs Containing PSRF:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.40% 67% D+ 65% D
Dividend Return 0.00% 21% F 14% F
Total Return 9.41% 66% D+ 64% D
Trailing 12 Months  
Capital Gain 20.57% 75% C 74% C
Dividend Return 0.01% 20% F 12% F
Total Return 20.58% 74% C 74% C
Trailing 5 Years  
Capital Gain 69.11% 79% B- 81% B-
Dividend Return 0.03% 13% F 7% C-
Total Return 69.14% 77% C+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.37% 75% C 76% C+
Dividend Return 11.37% 74% C 75% C
Total Return 0.00% 14% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 14.25% 52% F 67% D+
Risk Adjusted Return 79.81% 90% A- 93% A
Market Capitalization 0.50B 71% C- 60% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.